nsc 354646 has been researched along with methoxy-morpholinyl-doxorubicin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosshard, G; Cavalli, F; Colli, E; D'Incalci, M; Geroni, C; Ghielmini, M; Pennella, G; Sessa, C; Torri, V | 1 |
1 other study(ies) available for nsc 354646 and methoxy-morpholinyl-doxorubicin
| Article | Year |
|---|---|
Hematotoxicity on human bone marrow- and umbilical cord blood-derived progenitor cells and in vitro therapeutic index of methoxymorpholinyldoxorubicin and its metabolites.
Topics: Antibiotics, Antineoplastic; Bone Marrow; Doxorubicin; Fetal Blood; Humans; Stem Cells; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1998 |